跳至主要内容
临床试验/NCT01508962
NCT01508962进行中(未招募)不适用

PRE-Symptomatic Studies in Amyotrophic Lateral Sclerosis

University of Miami1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
1
主要终点
Phenoconversion

研究概览

简要总结

The goal of PRESS-ALS is to study the earliest manifestations of disease in people with early ALS in whom some areas of the body are not yet affected.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is a male or female, aged at least 18 years.
  • Subject is affected with ALS (familial or sporadic).
  • Subject has at least one limb in which there is no symptomatic upper and lower motor neuron dysfunction.
  • Subject is willing and able to comply with all study procedures.
  • Subject agrees to provide signed and dated informed consent form.
  • Control group:
  • Subject is a male or female, aged at least 18 years.
  • Subject is not affected with ALS or an ALS-related disorder.
  • Subject does not have a family history (i.e., at least 2 biological relatives) of ALS or an ALS-related disorder.
  • Subject is willing and able to comply with all study procedures.
  • Subject agrees to provide signed and dated informed consent form.
  • Exclusion Criterion
  • Any condition or situation which, in the PI's opinion, could confound the biomarker data or may interfere significantly with the individual's participation and compliance with the study protocol, including but not limited to neurological, psychological and/or medical conditions (e.g., multiple sclerosis, neuropathy, myelopathy).

排除标准

  • 未提供

结局指标

主要结局

Phenoconversion

时间窗: Every three months over the course of one year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Benatar

Professor of Neurology

University of Miami

研究点 (1)

Loading locations...

相似试验

PRE-Symptomatic Studies in Amyotrophic Lateral... | 临床试验